| VERA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VERA shares outstanding history going back to 5/14/2021:
Also see: VERA Market Cap History VERA YTD Return |
As of 5/1/2026 Vera Therapeutics has 71.78 million VERA shares outstanding. Investors often track the VERA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows VERA share count trends over time, with 22 historical shares outstanding datapoints presented, dating back to 5/14/2021.

| VERA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the VERA shares outstanding history going back to 5/14/2021:
Also see: VERA Market Cap History VERA YTD Return |
| VERA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||
VERA Historical Shares Outstanding: +28.93% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||
| VERA Stock Price Chart |
| About Vera Therapeutics Inc |
| Vera Therapeutics, Inc. is a late-stage biotechnology company. Co. is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Its product candidate, atacicept, is a self-administered fusion protein that blocks both a B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL) which stimulates B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. Co. is also engaged in developing MAU868, a monoclonal antibody designed to neutralize infection with BK Virus, a polyomavirus that can have devastating consequences in certain settings such as kidney transplants. We show 22 historical shares outstanding datapoints in our coverage of VERA's shares outstanding history. Understanding the changing numbers of VERA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VERA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VERA by allowing them to research VERA shares outstanding history as well as any other stock in our coverage universe. |
| VERA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| VERA Share Performance |
| Shares Outstanding Peers |
| Vera Therapeutics (VERA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
VERO Shares Outstanding History VERU Shares Outstanding History VERV Shares Outstanding History VICL Shares Outstanding History VIE Shares Outstanding History VIGL Shares Outstanding History VINC Shares Outstanding History VIR Shares Outstanding History VIRI Shares Outstanding History VIRX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.